A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML

Blood Cancer Journal

Volumn 6, Issue , 2016, Pages

  Krysiak, K ^a   Christopher, M J ^a   Skidmore, Z L ^a   Demeter, R T ^a   Magrini, V ^a   Kunisaki, J ^a   O'Laughlin, M ^a   Duncavage, E J ^a   Miller, C A ^a   Ozenberger, B A ^a   Griffith, M ^a,b   Wartman, L D ^a,b   Griffith, O L ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; NUCLEOPHOSMIN; PROTEIN TYROSINE KINASE INHIBITOR;

ACUTE MYELOBLASTIC LEUKEMIA; CELL CLONE; CHROMOSOME 7; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; COPY NUMBER VARIATION; EXOME; GENE DELETION; GENE FREQUENCY; GENETIC VARIABILITY; GENOMICS; HEMATOPOIESIS; HUMAN; LETTER; LEUKEMIA REMISSION; LEUKEMOGENESIS; MISSENSE MUTATION; PHILADELPHIA CHROMOSOME NEGATIVE CELL; SOMATIC MUTATION; TRISOMY 8; BIOPSY; BLAST CELL CRISIS; CASE REPORT; DISEASE COURSE; GENETICS; HIGH THROUGHPUT SEQUENCING; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; PATHOLOGY; PHILADELPHIA 1 CHROMOSOME;

BIOPSY; BLAST CRISIS; DISEASE PROGRESSION; EXOME; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; PHILADELPHIA CHROMOSOME;

EID: 84963566199     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2016.18     Document Type: Letter

References (15)

1. Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T, et al. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia. 2004; 19: 460-463.
2. Bumm T. Emergence of clonal cytogenetic abnormalities in Ph-cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. Blood. 2002; 101: 1941-1949.
3. Terre C, Eclache V, Rousselot P, Imbert M, Charrin C, Gervais C, et al. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia. 2004; 18: 1340-1346.
4. Deininger MWN, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M, et al. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells. Cancer. 2007; 110: 1509-1519.
5. Kovitz C, Kantarjian H, Garcia-Manero G, Abruzzo LV, Cortes J. Myelodysplastic syndromes, and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood. 2006; 108: 2811-2813.
6. Perel JM, McCarthy C, Walker O, Irving I, Williams B, Kennedy GA. Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate. Haematologica. 2005; 90 (Suppl): ECR25.
7. Schmidt M, Rinke J, Schäfer V, Schnittger S, Kohlmann A, Obstfelder E, et al. Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status. Leukemia. 2014; 28: 2292-2299.
8. Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S, et al. Association between mutation clearance after induction therapy, and outcomes in acute myeloid leukemia. JAMA. 2015; 314: 811-822.
9. Griffith M, Griffith OL, Smith SM, Ramu A, Callaway MB, Brummett AM, et al. Genome modeling system: a knowledge management platform for genomics. PLoS Comput Biol. 2015; 11: e1004274.
10. Larsson N, Billstrom R, Lilljebjorn H, Lassen C, Richter J, Ekblom M, et al. Genetic analysis of dasatinib-Treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells. Cancer Genet Cytogenet. 2010; 199: 89-95.
11. Grossmann V, Tiacci E, Holmes AB, Kohlmann A, Martelli MP, Kern W, et al. Wholeexome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood. 2011; 118: 6153-6163.
12. Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC, et al. The origin, and evolution of mutations in acute myeloid leukemia. Cell. 2012; 150: 264-278.
13. Cancer Genome Atlas Research Network. Genomic, and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013; 368: 2059-2074.
14. Kurtovic-Kozaric A, Przychodzen B, Singh J, Konarska MM, Clemente MJ, Otrock ZK, et al. PRPF8 defects cause missplicing in myeloid malignancies. Leukemia. 2015; 29: 126-136.
15. Georgiou G, Efthymiou A, Vardounioti I, Boutsikas G, Angelopoulou MK, Vassilakopoulos TP, et al. Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib. Leukemia. 2012; 26: 824-826.